Citigroup upgraded Calithera Biosciences Inc. (Nasdaq: CALA) from a Neutral rating to a Buy rating lifting the stock price $1.15 to close at $8.10.
Cala Biosciences upgraded
February 16, 2018 at 19:15 PM EST
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |